Literature DB >> 22488672

The roles of microRNAs in sarcomas.

Ruth Drury1, Eldo T Verghese, Thomas A Hughes.   

Abstract

MicroRNAs are a class of small regulatory RNAs that influence the stabilities and translational efficiencies of target mRNAs. They have been implicated in an increasing number of biological processes, including carcinogenesis. A huge body of literature exists documenting up- or down-regulation of specific microRNAs during carcinogenesis and identifying molecular pathways by which these microRNAs influence every aspect of cancer development, including proliferation, angiogenesis, and metastasis. These studies have provided many insights into basic cancer biology as well as allowing identification of novel biomarkers and potential drug targets. However, the vast bulk of this literature concerns solid epithelial tumours, while sarcomas remain relatively under-studied. The purpose of this article is to review the roles of microRNAs in sarcomas and to highlight microRNAs or related molecular pathways that demonstrate consistent roles within individual or across sarcoma subtypes, with a view to identifying the key regulatory molecules. Further insights into sarcoma biology may be particularly valuable since sarcomas represent a tumour group with a particularly poor prognosis and rather limited treatment options.
Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22488672     DOI: 10.1002/path.4037

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  7 in total

1.  A selective screening platform reveals unique global expression patterns of microRNAs in a cohort of human soft-tissue sarcomas.

Authors:  Peter Y Yu; Mumtaz Y Balkhi; Katherine J Ladner; Hansjuerg Alder; Lianbo Yu; Xiaokui Mo; William G Kraybill; Denis C Guttridge; O Hans Iwenofu
Journal:  Lab Invest       Date:  2016-02-15       Impact factor: 5.662

2.  Identification, by systematic RNA sequencing, of novel candidate biomarkers and therapeutic targets in human soft tissue tumors.

Authors:  Anne E Sarver; Aaron L Sarver; Venugopal Thayanithy; Subbaya Subramanian
Journal:  Lab Invest       Date:  2015-06-29       Impact factor: 5.662

Review 3.  MicroRNAs in the pathobiology of sarcomas.

Authors:  Anne E Sarver; Subbaya Subramanian
Journal:  Lab Invest       Date:  2015-06-29       Impact factor: 5.662

4.  MicroRNA-3148 acts as molecular switch promoting malignant transformation and adipocytic differentiation of immortalized human bone marrow stromal cells via direct targeting of the SMAD2/TGFβ pathway.

Authors:  Radhakrishnan Vishnubalaji; Ramesh Elango; Muthurangan Manikandan; Abdul-Aziz Siyal; Dalia Ali; Ammar Al-Rikabi; Dana Hamam; Rimi Hamam; Hicham Benabdelkamel; Afshan Masood; Ibrahim O Alanazi; Assim A Alfadda; Musaad Alfayez; Abdullah Aldahmash; Moustapha Kassem; Nehad M Alajez
Journal:  Cell Death Discov       Date:  2020-09-01

Review 5.  MicroRNAs in soft tissue sarcomas: overview of the accumulating evidence and importance as novel biomarkers.

Authors:  Tomohiro Fujiwara; Toshiyuki Kunisada; Ken Takeda; Koji Uotani; Aki Yoshida; Takahiro Ochiya; Toshifumi Ozaki
Journal:  Biomed Res Int       Date:  2014-08-04       Impact factor: 3.411

6.  MicroRNAs as Potential Biomarkers in the Differential Diagnosis of Lipomatous Tumors and Their Mimics.

Authors:  Hui Min Tan; He Cheng; Yew Chung Tang; Sai Mun Leong; Poh Yin Teo; Chi Kuen Lee; Victor Kwan Min Lee; Susan Swee-Shan Hue
Journal:  Int J Mol Sci       Date:  2022-07-15       Impact factor: 6.208

7.  Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes.

Authors:  S U Lauvrak; E Munthe; S H Kresse; E W Stratford; H M Namløs; L A Meza-Zepeda; O Myklebost
Journal:  Br J Cancer       Date:  2013-09-24       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.